171 related articles for article (PubMed ID: 36933212)
1. Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?
Chen Y; Yu J; Meng X
Oncologist; 2023 May; 28(5):376-378. PubMed ID: 36933212
[TBL] [Abstract][Full Text] [Related]
2. Role of Postoperative Radiotherapy in Patients With Completely Resected pIIIA-N2 Non-Small Cell Lung Cancer.
Yamasaki N; Kim YH; Iwatsubo S; Nishimura Y; Funada Y
Clin Lung Cancer; 2022 May; 23(3):e171-e172. PubMed ID: 34756510
[No Abstract] [Full Text] [Related]
3. Postoperative radiotherapy in completely resected, early-stage, non-small-cell lung cancer: reflections and future directions.
Granone P; Keller S; Trodella L; Cesario A; Margaritora S; Porziella V; Valente S; Corbo GM; d'Angelillo R
Lancet Oncol; 2002 Oct; 3(10):589-90; discussion 590-1. PubMed ID: 12372718
[No Abstract] [Full Text] [Related]
4. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
5. [A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer].
Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):195-6. PubMed ID: 11355584
[No Abstract] [Full Text] [Related]
6. Postoperative radiotherapy for patients with completely resected stage IIIA-N2 non-small cell lung cancer: opt-in or opt-out.
Zhu L; Xia B; Ma S
Thorac Cancer; 2022 Mar; 13(5):659-663. PubMed ID: 35106937
[TBL] [Abstract][Full Text] [Related]
7. [Effect of postoperative thoracic radiotherapy on the survival of patients with stage IIIA (N2 disease) non-small-cell lung cancer].
Chabowski M; Orłowski TM
Pol Merkur Lekarski; 2004 Oct; 17(100):345-8. PubMed ID: 15690698
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-N2 non-small cell lung cancer.
Predina J; Suliman R; Potter AL; Panda N; Diao K; Lanuti M; Muniappan A; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2023 May; 165(5):1696-1709.e4. PubMed ID: 36610886
[TBL] [Abstract][Full Text] [Related]
10. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
Johnson DH; Rusch VW; Turrisi AT
J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
[No Abstract] [Full Text] [Related]
11. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy in resected N2 non-small-cell lung cancer: Lung ART.
Hendriks LEL; De Ruysscher DKM
Lancet Oncol; 2022 Jan; 23(1):8-9. PubMed ID: 34919825
[No Abstract] [Full Text] [Related]
13. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
14. [No more postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and mediastinal N2 involvement? A radiotherapeutic interpretation of the Lung ART Trial].
Weykamp F; Adeberg S
Strahlenther Onkol; 2022 Jun; 198(6):598-599. PubMed ID: 35364688
[No Abstract] [Full Text] [Related]
15. Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality.
Arriagada R; Le Péchoux C; Pignon JP
Lung Cancer; 2003 Dec; 42 Suppl 1():S57-64. PubMed ID: 14611916
[TBL] [Abstract][Full Text] [Related]
16. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
17. [Commentary for the work L. Kepka et al.: Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice].
Jodkiewicz ZM
Pneumonol Alergol Pol; 2007; 75(3):211-2. PubMed ID: 17966094
[No Abstract] [Full Text] [Related]
18. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.
Le Péchoux C
Oncologist; 2011; 16(5):672-81. PubMed ID: 21378080
[TBL] [Abstract][Full Text] [Related]
19. Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China.
Zhou S; Zhai Y; Zhao K; Men Y; Meng X; Hui Z
Radiat Oncol; 2023 Jan; 18(1):17. PubMed ID: 36698150
[TBL] [Abstract][Full Text] [Related]
20. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
